Loading clinical trials...
Loading clinical trials...
This is a research study designed to look at the efficacy and safety of daptomycin given at a dose of 6 mg/kg or 8 mg/kg in subjects being treated for prosthetic hip or knee infections caused by Staph...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT06827496 · Osteomyelitis Acute, Septic Arthritis, and more
NCT03594344 · Diabetes Mellitus, Claudication, Intermittent, and more
NCT02979951 · Bacterial Infections, Bone Diseases, Infectious, and more
NCT05607888 · Nasal Neoplasm, Nasal Neoplasm Benign, and more
NCT07266753 · Osteomyelitis of Lower Extremities, Osteomyelitis - Foot, and more
UAMS College of Medicine
Little Rock, Arkansas
South Denver Infectious Disease Associates, PC
Englewood, Colorado
Kane and Davis Associates
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions